Clinical trial
A Randomized, Controlled, Pilot Study to Evaluate Safety and Feasibility of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction Presenting With TIMI 0 or 1 and Symptom Duration ≤ 12 Hours Treated Adjunct to Percutaneous Coronary Intervention (PCI) Compared to Standard PCI.
NCT04958421 is registered in ClinicalTrials.gov with Miracor Medical SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Pilot Study to Evaluate Safety and Feasibility of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction Presenting With TIMI 0 or 1 and Symptom Duration ≤ 12 Hours Treated Adjunct to Percutaneous Coronary Intervention (PCI) Compared to Standard PCI.
- Lead sponsor
- Miracor Medical SA
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 14, 2022
- Completion date
- February 6, 2023
- Enrollment
- 25 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
inferior wall myocardial infarction, stemi - st elevation myocardial infarction